Metropolitan Life Insurance Company (MetLife)’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-7,678
| Closed | -$64.1K | – | 2767 |
|
|
2021
Q4 | $64.1K | Sell |
7,678
-1,890
| -20% | -$15.8K | ﹤0.01% | 2668 |
|
|
2021
Q3 | $71.1K | Buy |
+9,568
| New | +$71.1K | ﹤0.01% | 2696 |
|
|
2018
Q2 | – | Sell |
-5,015
| Closed | -$112K | – | 2506 |
|
|
2018
Q1 | $112K | Buy |
+5,015
| New | +$112K | ﹤0.01% | 2234 |
|
|
2017
Q4 | – | Sell |
-11,093
| Closed | -$173K | – | 2530 |
|
|
2017
Q3 | $173K | Buy |
+11,093
| New | +$173K | ﹤0.01% | 2338 |
|